Undercovered Dozen: Incyte, Annaly Capital, ImmunityBio And More
Source: SeekingAlpha
2026-01-27 09:00:00 ET
The Undercovered Dozen is a weekly Seeking Alpha editor-curated series highlighting 12 articles on lesser-covered stocks from the previous seven days. We hope this provides ideas and inspires discussion among the community....
Read the full article on Seeking Alpha
For further details see:
Undercovered Dozen: Incyte, Annaly Capital, ImmunityBio And More
ImmunityBio Inc.
NASDAQ: IBRX
IBRX Trading
-5.32% G/L:
$8.087 Last:
10,815,557 Volume:
$8.52 Open:
IBRX Latest News
March 13, 2026 07:30:00 am
ImmunityBio Achieves Milestone with Large-Scale NK Cell Production and Cryopreservation from Over 60 Healthy and Cancer Donors
March 09, 2026 07:30:00 am
ImmunityBio Announces Resubmission of Supplemental BLA to the FDA for ANKTIVA® Plus BCG in BCG-Unresponsive NMIBC with Papillary Disease Following Agency Review of Additional Data
March 05, 2026 10:20:00 am
Forget ImmunityBio: This Big?Cap Pharma Is the Safer Play on Next?Gen Cancer Therapies
February 27, 2026 07:30:00 am
ImmunityBio to Provide a Business Update and Review Financial Results for FY 2025 on Tuesday, March 3, 2026
IBRX Stock Data
$6,497,322,803
300,611,373
0.32%
122
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
